Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2018
Source ID
10.1016/j.neuroimage.2018.08.042

Entities

People

  • Alexandre Routier
  • Anne Bertrand
  • Arnaud Marcoux
  • Hugo Bertin
  • John T. Wen
  • Jorge Samper-gonzález
  • Jérémy Guillon
  • Marie-odile Habert
  • Michael Bacci
  • Ninon Burgos
  • Olivier Colliot
  • Pascal Lu
  • Sabrina Fontanella
  • Simona Bottani
  • Stanley Durrleman
  • Theodoros Evgeniou

Organizations

  • AbbVie
  • Agence Nationale de la Recherche
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • European Research Council
  • GE HealthCare
  • Hoffmann-La Roche
  • Horizon 2020
  • Innogenetics
  • Johnson & Johnson
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Perrigo Company Plc
  • Pfizer
  • Roche (United States)
  • Seventh Framework Programme
  • Takeda Pharmaceutical Company
  • United States Department of Defense